PD-L1

13 registered clinical trials studyying PD-L1 — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor NCT07442292	Peking University Cancer Hospital & Institute	—
Recruiting	LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study NCT07312422	Zhejiang Provincial People's Hospital	Phase 1 / Phase 2
Not Yet Recruiting	Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC NCT06699498	The First Affiliated Hospital with Nanjing Medical University	Phase 2
Recruiting	A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Ma NCT06635954	Oxford Biodynamics Inc.	—
Recruiting	68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers NCT06754345	The First Affiliated Hospital of Xiamen University	—
Unknown	Radiomics for prEdiction of lunG cAncer biologY NCT05819905	Poitiers University Hospital	—
Recruiting	Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial. NCT05397769	Sun Yat-sen University	Phase 2
Unknown	PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor NCT05156515	Peking University Cancer Hospital & Institute	N/A
Active Not Recruiting	PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Pr NCT04634058	Shanghai Zhongshan Hospital	Phase 2
Completed	Immune Profiling After HDR in Local Relapsed Prostate Cancer NCT04247217	Maastricht Radiation Oncology	—
Unknown	Genetic Mutation in Recurrent Cervical Cancer NCT04191226	Lei Li	—
Unknown	Genetic Mutation in Epithelial Ovarian Cancer NCT04191252	Lei Li	—
Unknown	Effect of Chemotherapy on PD-L1 in NSCLC NCT03701607	Baodong Qin	—